FI4188327T3 - Yhdistelmähoito inhalaatioannosteluun - Google Patents
Yhdistelmähoito inhalaatioannosteluunInfo
- Publication number
- FI4188327T3 FI4188327T3 FIEP21755917.8T FI21755917T FI4188327T3 FI 4188327 T3 FI4188327 T3 FI 4188327T3 FI 21755917 T FI21755917 T FI 21755917T FI 4188327 T3 FI4188327 T3 FI 4188327T3
- Authority
- FI
- Finland
- Prior art keywords
- composition according
- solution composition
- pharmaceutical solution
- long
- acting
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20382710 | 2020-07-31 | ||
| PCT/EP2021/071369 WO2022023515A1 (en) | 2020-07-31 | 2021-07-30 | Combination therapy for inhalation administration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI4188327T3 true FI4188327T3 (fi) | 2025-07-25 |
Family
ID=72039503
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP21755917.8T FI4188327T3 (fi) | 2020-07-31 | 2021-07-30 | Yhdistelmähoito inhalaatioannosteluun |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20230270754A1 (https=) |
| EP (1) | EP4188327B1 (https=) |
| JP (1) | JP7828949B2 (https=) |
| KR (1) | KR20230052903A (https=) |
| CN (1) | CN115989032A (https=) |
| AU (1) | AU2021314977B2 (https=) |
| BR (1) | BR112023001689A2 (https=) |
| CA (1) | CA3186956A1 (https=) |
| ES (1) | ES3037198T3 (https=) |
| FI (1) | FI4188327T3 (https=) |
| MX (1) | MX2023001201A (https=) |
| PL (1) | PL4188327T3 (https=) |
| WO (1) | WO2022023515A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230270754A1 (en) | 2020-07-31 | 2023-08-31 | Chemo Research, S.L. | Combination therapy for inhalation administration |
| WO2026057872A1 (en) * | 2024-09-16 | 2026-03-19 | Invox Belgium Nv | Inhalable compositions |
| CN121714579A (zh) * | 2026-02-25 | 2026-03-24 | 上海臣邦医药科技股份有限公司 | 一种三联复方吸入制剂的药物组合物及其制备方法和应用 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851317A (en) | 1987-11-04 | 1989-07-25 | E. I. Du Pont De Nemours And Company | Laminar flow toning station having conductive and nonconductive elements therein |
| UA62917C2 (en) * | 1995-06-27 | 2004-01-15 | Berinher Inhelheim Kg | Medicinal composition for generating propellant-free aerosols |
| DE19536902A1 (de) | 1995-10-04 | 1997-04-10 | Boehringer Ingelheim Int | Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung |
| DE19653969A1 (de) | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
| DE59901669D1 (de) * | 1998-10-17 | 2002-07-11 | Boehringer Ingelheim Pharma | Lagerfähiges wirkstoffkonzentrat mit formoterol |
| AU2000250701B2 (en) | 2000-05-22 | 2004-07-01 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| FI20002216A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit astman hoitoon |
| FI20002215A0 (fi) | 2000-10-06 | 2000-10-06 | Orion Yhtymae Oyj | Yhdistelmäpartikkelit |
| US20020137764A1 (en) * | 2000-10-31 | 2002-09-26 | Karin Drechsel | Inhalable formulation of a solution containing a tiotropium salt |
| CA2436540C (en) | 2000-10-31 | 2008-01-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and corticosteroids |
| US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
| JP2008538758A (ja) | 2005-04-23 | 2008-11-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗コリン作用薬に加えてベータ受容体刺激薬及びステロイドを含有する吸入用の医薬組成物 |
| ITMI20051999A1 (it) * | 2005-10-21 | 2007-04-22 | Eratech S R L | Formulazioni inalatorie di farmaci in fora di polvere secca per somministrazione come tale o con nebulizzatore e dotate di elevata erogabilita' respirabilita' e stabilita' |
| US20070293460A1 (en) | 2005-10-31 | 2007-12-20 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| US20070098644A1 (en) | 2005-10-31 | 2007-05-03 | Richie's Pharmacy And Medical Supply, Incorporated | Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease |
| DE102006023756A1 (de) | 2006-05-20 | 2007-11-29 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Ethanolhaltige Aerosolformulierung für die Inhalation |
| UY30542A1 (es) | 2006-08-18 | 2008-03-31 | Boehringer Ingelheim Int | Formulacion de aerosol para la inhalacion de agonistas beta |
| EP2515855B3 (en) | 2009-12-23 | 2023-05-03 | Chiesi Farmaceutici S.p.A. | Combination therapy for COPD |
| SG181870A1 (en) | 2009-12-23 | 2012-07-30 | Chiesi Farma Spa | Aerosol formulation for copd |
| BR112012015334A2 (pt) | 2009-12-23 | 2016-03-15 | Chiesi Farma Spa | terapia combinada para doença pulmonar obstrutiva crônica |
| US20120220557A1 (en) | 2011-02-17 | 2012-08-30 | Chiesi Farmaceutici S.P.A. | Liquid propellant-free formulation comprising an antimuscarinic drug |
| BR112015010842B1 (pt) | 2012-12-21 | 2021-03-30 | Boehringer Ingelheim Vetmedica Gmbh | Uso da ciclesonida para o tratamento de doença das vias respiratórias em cavalos |
| RS57687B1 (sr) | 2013-12-30 | 2018-11-30 | Chiesi Farm Spa | Pod pritiskom stabilan aerosolni rastvor kompozicije glikopironijum bromida i kombinacije formoterola |
| GEAP201814192A (en) | 2013-12-30 | 2018-02-26 | Chiesi Farm Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
| US9554992B2 (en) | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
| ES2759247T3 (es) | 2014-06-18 | 2020-05-08 | Boehringer Ingelheim Vetmedica Gmbh | Antagonistas muscarínicos y combinaciones de estos para el tratamiento de enfermedades de las vías respiratorias en caballos |
| GB201520862D0 (en) * | 2015-11-25 | 2016-01-13 | Jagotec Ag | Pharmaceutical composition |
| US10098837B2 (en) | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
| WO2020167893A1 (en) | 2019-02-13 | 2020-08-20 | Molecular Infusions, Llc | Methods for non-irritating pulmonary administration of cannabinoids using soft mist inhalers |
| US20230270754A1 (en) | 2020-07-31 | 2023-08-31 | Chemo Research, S.L. | Combination therapy for inhalation administration |
-
2021
- 2021-07-30 US US18/007,426 patent/US20230270754A1/en active Pending
- 2021-07-30 CA CA3186956A patent/CA3186956A1/en active Pending
- 2021-07-30 AU AU2021314977A patent/AU2021314977B2/en active Active
- 2021-07-30 EP EP21755917.8A patent/EP4188327B1/en active Active
- 2021-07-30 KR KR1020237006563A patent/KR20230052903A/ko active Pending
- 2021-07-30 WO PCT/EP2021/071369 patent/WO2022023515A1/en not_active Ceased
- 2021-07-30 JP JP2023506220A patent/JP7828949B2/ja active Active
- 2021-07-30 PL PL21755917.8T patent/PL4188327T3/pl unknown
- 2021-07-30 CN CN202180051794.2A patent/CN115989032A/zh active Pending
- 2021-07-30 MX MX2023001201A patent/MX2023001201A/es unknown
- 2021-07-30 FI FIEP21755917.8T patent/FI4188327T3/fi active
- 2021-07-30 BR BR112023001689A patent/BR112023001689A2/pt unknown
- 2021-07-30 ES ES21755917T patent/ES3037198T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7828949B2 (ja) | 2026-03-12 |
| CA3186956A1 (en) | 2022-02-03 |
| AU2021314977A1 (en) | 2023-03-02 |
| CN115989032A (zh) | 2023-04-18 |
| KR20230052903A (ko) | 2023-04-20 |
| PL4188327T3 (pl) | 2025-09-01 |
| JP2023540171A (ja) | 2023-09-22 |
| BR112023001689A2 (pt) | 2023-05-02 |
| WO2022023515A1 (en) | 2022-02-03 |
| US20230270754A1 (en) | 2023-08-31 |
| EP4188327A1 (en) | 2023-06-07 |
| EP4188327B1 (en) | 2025-05-28 |
| ES3037198T3 (en) | 2025-09-30 |
| AU2021314977B2 (en) | 2025-03-13 |
| MX2023001201A (es) | 2023-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6563950B2 (ja) | グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物 | |
| US10179139B2 (en) | Pharmaceutical composition | |
| JP6534397B2 (ja) | グリコピロニウム臭化物およびホルモテロールの組合せの安定な加圧エアゾール溶液組成物 | |
| US20170027908A1 (en) | Pharmaceutical Composition | |
| US20130074834A1 (en) | Pharmaceutical Combinations | |
| FI4188327T3 (fi) | Yhdistelmähoito inhalaatioannosteluun | |
| WO2014016548A2 (en) | Pharmaceutical composition | |
| CN104918604A (zh) | 药物组合物 | |
| JP2019528316A5 (https=) | ||
| NZ600789A (en) | Aerosol formulation for copd | |
| JP2023540171A5 (https=) | ||
| JP2025527924A (ja) | 呼吸器系疾患を予防または治療するための吸入用薬物組成物 | |
| AU2015275933A1 (en) | Pharmaceutical composition comprising a beta-2-agonist and anticholinergic agent | |
| WO2012010854A1 (en) | Inhalation formulations comprising carmoterol in combination with a corticosteroid | |
| TWI922835B (zh) | 預防或治療呼吸系統疾病的吸入用藥物組合物 | |
| TR2023012447A1 (tr) | İti̇ci̇ gaz i̇çermeyen sivi farmasöti̇k bi̇leşi̇mler | |
| TR2023013248A1 (tr) | İnhale edi̇lebi̇li̇r formda i̇ti̇ci̇ gaz i̇çermeyen farmasöti̇k bi̇leşi̇mler | |
| TR2023016004A1 (tr) | İnhalasyona uygun bi̇r muskari̇ni̇k ve bi̇r betami̇meti̇k etken madde i̇çeren farmasöti̇k bi̇leşi̇mler | |
| TR2023012456A1 (tr) | İnhale edi̇lebi̇li̇r formda sivi bi̇leşi̇mler | |
| TR2023013250A1 (tr) | İti̇ci̇ gaz i̇çermeyen farmasöti̇k aerosol bi̇leşi̇mler | |
| TR2023014905A1 (tr) | Steroi̇d i̇çeren aerosol bi̇leşi̇mler | |
| TR2023014913A1 (tr) | İnhalasyon yoluyla kullanima uygun steroi̇d i̇çeren aerosol bi̇leşi̇mler | |
| TR2023016001A1 (tr) | Solunabi̇li̇r formda bi̇r steroi̇d etken madde i̇çeren farmasöti̇k bi̇leşi̇mler | |
| TR2023016002A1 (tr) | İnhalasyona uygun steroi̇d bi̇r etken madde i̇çeren farmasöti̇k bi̇leşi̇mler | |
| TR2023016009A1 (tr) | İnhalasyon yoluyla kullanima uygun bi̇r muskari̇ni̇k antagoni̇st etken madde i̇çeren farmasöti̇k bi̇leşi̇mler |